Browse studies

Find your next paid study

37 recruiting studies matching your filters

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients With MIBC (RAD-SG).

The purpose of this study is to examine the safety and tolerability of treatment with concurrent Sacituzumab Govitecan (SG) and adaptive radiation therapy. The…

Localized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma

Estimated

~$10 – $7,500

Shilpa Gupta, MDNCT05833867

Phase 1

A Phase I Microtrial With PLZ4-Coated Paclitaxel-Loaded Micelles (PPM) in Patients With Recurrent or Refractory Non-Myoinvasive Bladder Cancer

This phase I trial tests the safety, tolerability and effectiveness of PLZ4-coated paclitacel-loaded micelles (PPM) in treating patients with non-muscle invasi…

Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more

Estimated

~$10 – $6,250

University of California, DavisNCT06173349

Phase 2

A Phase 2, Randomized, Open-label Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) for Organ Preservation in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

The goal of this clinical trial is to learn if gemcitabine/cisplatin plus cemiplimab with or without fianlimab works to treat bladder cancer in adults. The mai…

Bladder CancerMuscle-Invasive Bladder Carcinoma

Estimated

~$10 – $6,250

Columbia UniversityNCT06571708

Observational

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of…

Bladder CancerNon-muscle-invasive Bladder CancerMuscle-Invasive Bladder Carcinoma

Estimated

~$10 – $6,250

University of VirginiaNCT05790850

Phase 4

An Assessment of Patient Position and Intravesical BCG Dwell Time

This phase IV trial studies whether there is a relationship between how a patient is positioned while receiving bacillus Calmette Guerin (BCG) within the bladd…

Non-Muscle Invasive Bladder Carcinoma

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT07474519

Bladder Bank (a Prospective Banking Study)

This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.

Bladder Carcinoma

Estimated

~$10 – $750

Mayo ClinicNCT06109857

Phase 2

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where i…

Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

The goal of this study is to better understand how to best treat participants with advanced bladder cancer who may not be able to tolerate all of the chemother…

Bladder CancerMetastatic Bladder CancerUnresectable Bladder Carcinoma+1 more

Estimated

~$10 – $1,125

Dana-Farber Cancer InstituteNCT06138561

Observational

Randomized Controlled Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the sta…

Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07234968

Phase 2

A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors

Patients with solid tumors that have high expression levels of EphrinB2 are treated with regimens that include EphrinB2 inhibitor, sEphB4-HSA. The primary obje…

Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma

Estimated

~$10 – $8,750

Vasgene Therapeutics, IncNCT06493552

Phase 1

Prophylactic Antibiotics in Radical Cystectomy With Urinary Diversion

Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral a…

Muscle-Invasive Bladder CarcinomaRadical CystectomyIleal Conduit+1 more

Estimated

~$10 – $6,250

University of MinnesotaNCT06190197

Phase 1

MC240502: Cancer CARE (Connected Access and Remote Expertise) Beyond Walls In-home iNtraVesIcal ThErapy (INVITE) Study - A Phase Ib/II, Single-Arm Trial of Delivering Intravesical Therapy for Bladder Cancer in Patients' Homes

This phase Ib/II trial compares the safety, tolerability and acceptability of intravesical chemotherapy given at home to in-clinic administration in patients w…

Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06704191